Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 19, 2019
May 7, 2020
f2b5ad51-4873-4c0b-b0c5-cfb4081aad18
Related Documents
Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentMarch 13, 2019Center for Drug Evaluation and Research
Marketing Status Notifications Under Section 506I of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentAugust 10, 2020Center for Drug Evaluation and Research
Pre-Launch Activities Importation Requests (PLAIR): Guidance for Industry
Guidance DocumentMarch 1, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.